IRCT20111024007892N10
Completed
Phase 2
Comparison the effect of oral calcitriol pulse therapy with oral daily calcitriol method in hemodiyalis paitients
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Secondary hyperparathyroidism of renal origin.
- Sponsor
- Mashhad University of Medical Sciences
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with chronic kidney disease (CKD) who are under chronic hemodialysis and need to receive Calcitriol for secondary hyperparathyroidism
- •Age less than 18 years
- •Serum bicarbonate more than 15 mEq/L
- •Serum albumin more than 3 g/dl
- •Hemoglobin more than 8 g/dl
Exclusion Criteria
- •Primary metabolic disorder
- •Intestinal malabsorption
- •Endocrine or liver disease
- •Malignancies
- •Receiving corticosteroid
- •Receiving rhGH
- •Hypocalcemia or hypercalcemia
- •hypophosphatemia or hyperphosphatemia
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
oral calcium and magnesium on the reduction of pmsPremenstrual syndrome.Premenstrual tension syndromeN94.3IRCT20160709028844N1Shahre-kord University of Medical Sciences195
Completed
Phase 3
Effect of Calciterol and Cinacalcate on hyperparathyroidismIRCT20190702044076N1Shahre-kord University of Medical Sciences60
Completed
Not Applicable
Evaluation of calcium effect in Children GastroenteritisAcute Gastroenteritis.other and unspecified gastroenteritis and colitis of infectious originIRCT2015110624900N1Iran University of Medical Science/Hazrat Aliasghar Hospital124
Recruiting
Phase 3
Calcitriol and cholecalciferol effect on cardiac biomarkersIRCT20150518022306N3Shiraz University of Medical Sciences180
Completed
Phase 2
Evaluation of the effect of calcitriol supplementation on diabetes control and its complications in hyperlipidemic patients with type 2 diabetes mellitus, Shiraz, 2009IRCT138806282480N1Shiraz university of medical sciences70